BC Platforms

BC Platforms

A global leader in providing a powerful data and technology platform for personalized medicine and drug development, accelerating the translation of insights into clinical practice. Learn more

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2017201820192020202120222023
Revenues<1m<1m<1m<1m<1m<1m<1m
% growth(8 %)4 %7 %34 %16 %22 %6 %

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Spinout

N/A

-
*

$10.0m

Series B
*

$15.0m

Series C
*

$20.0m

Growth Equity VC
Total Funding€40.9m

Recent News about BC Platforms

Edit
More about BC Platformsinfo icon
Edit

BC Platforms specializes in genomic data management solutions aimed at advancing precision medicine and research. The company integrates clinical and genetic data to provide actionable insights for healthcare providers, research institutions, and pharmaceutical companies. Operating in the global healthcare and biotechnology markets, BC Platforms employs a subscription-based business model, offering its software as a service (SaaS). Revenue is generated through licensing fees, data analytics services, and partnerships with research organizations. The company serves a diverse clientele, including hospitals, universities, and biotech firms, helping them to leverage big data for improved patient outcomes and innovative research.

Keywords: Genomic data, precision medicine, clinical data, genetic insights, healthcare analytics, biotechnology, SaaS, data integration, research partnerships, patient outcomes.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by BC Platforms

Edit
Medexprim
ACQUISITION by BC Platforms Dec 2023
4Pharma
ACQUISITION by BC Platforms Jun 2023